Mannkind (MNKD) Net Margin (QoQ) (2016 - 2026)

Mannkind (MNKD) Net Margin (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Mannkind 1.19 Bn 1.08 Bn 94.97 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 103.00
Mar 31, 2026 -419.00
Dec 31, 2025 -2,396.00
Sep 30, 2025 888.00
Jun 30, 2025 -1,596.00
Mar 31, 2025 714.00
Dec 31, 2024 -682.00
Sep 30, 2024 1,926.00
Jun 30, 2024 -1,882.00
Mar 31, 2024 1,364.00
Dec 31, 2023 -457.00
Sep 30, 2023 1,781.00
Jun 30, 2023 1,328.00
Mar 31, 2023 2,566.00
Dec 31, 2022 -580.00
Sep 30, 2022 10,964.00
Jun 30, 2022 6,318.00
Mar 31, 2022 742.00
Dec 31, 2021 -20,429.00
Sep 30, 2021 13,266.00